Navigation Links
Malaria Vaccine May Be 10 Years Away

Scientists in past centuries called the sickness by the Italian phrase 'malaria' — or 'bad air' — for the supposedly disease-bearing zephyrs wafting from swamps.

These days, scientists know malaria is spread by mosquitos. // And they say ill winds are buffeting their attempts to halt the spread of a disease that kills 1 million people a year, AP reports.

'We need to stress that the situation is bad. The number of deaths are rising, infections are rising,' said Pierre Druilhe, head of the biomedical unit at France's Pasteur Institute.

Scientists say it could take more than 10 years before a fully effective malaria vaccine is approved for use.

Hundreds of malaria experts gathered this week in Yaounde, Cameroon, for a conference on the disease. And while many scientists described solid recent advancements and reason for cautious optimism, others said the news isn't good for Africa.

While malaria has been all but eradicated in wealthy nations, scientists say they're hindered in Africa by twin hurdles: insecticide resistance in mosquitoes and drug resistance in the parasite.

Malaria is spread by mosquitoes and causes wracking pain, fever and, if left untreated, death. It kills more African children than any other disease, and is the leading cause of death of those under 5 in sub-Saharan Africa.

African poverty means few buyers for even relatively inexpensive insecticide-treated bed nets, so many companies shy away from producing them, scientists say. And anti-malarial drugs can be costly.

Malaria prevention is 'in trouble,' Brian Greenwood of the London School of Hygiene and Tropical Medicine said by telephone from Cameroon.

For Greenwood, the main problem is increased resistance to drugs, particularly the longtime mainstay, chloroquine, which is relatively cheap to produce in mass quantities.

Medical workers are turning to a new drug called artemisinin, derived fr om an herb indigenous to Asia. Drawing on lessons learned from treating HIV and AIDS, doctors are using artemisinin with other drugs. But production is slow and expensive.

'It's a plant that takes 18 months to grow. You can't just say that you need 20 million doses right now,' Greenwood said.

Without chloroquine and the insecticide DDT — which helped eradicate malaria in the United States and Europe but was ultimately believed by many to cause cancer and harm the environment — anti-malaria campaigners say they've lost two key weapons.

'It's pretty straightforward,' Druilhe said by telephone from Cameroon. 'We have today far less means to control malaria than 50 years ago.'

This means, he said, that 'the next decade will be a very bad decade.'

As for new insecticides, scientists say there are only pockets of resistance in the mosquitoes that carry malaria — at least so far.

'If you had in one place a high level of resistance to both drugs and insecticides, it would be a disaster,' Greenwood said.

Malaria, with over a half billion infections worldwide, is a major contributor to African poverty, scientists say, cutting billions from gross domestic product while weighing on health care systems.

But not all is calamity. Scientists say they've identified a resurgence in public and political interest in malaria over the past decade, a change they ascribe to greater media coverage and increased tourism in countries where the disease is a threat.

Malaria, Greenwood said, 'has dropped into the mainstream.'

Plus, scientists are increasingly banding together to study the problem — as they did this week in Cameroon — while philanthropists like Microsoft founder Bill Gates have donated huge amounts of money to fight the disease.

But Druilhe said more cash is needed. 'There's a need for the developing countries to put some pressure on the rich countries of t he north,' h said.
'"/>




Related medicine news :

1. Malaria strikes Munger tribals
2. Sponging Cattle betters spraying in eradicating Malaria
3. Gene researchers make Malaria-resistant mosquito
4. More Treatment Options For Malaria
5. Scientists Unveil Mechanism Behind Resistance to Severe Malaria
6. Jharkhand reports 13,000 Malaria cases
7. Researchers Discover Protein That Causes Malaria
8. Malarial gene ascertained
9. Artesunate Is Better For Malaria Than Quinine
10. New Strategies For Effective Treatment Of Malaria
11. Chloroquine and Primaquine combination Malarial drug for resistant parasites.
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/26/2016)... ... May 26, 2016 , ... The Woodlands at John ... a new model of care for living and healing, celebrated its grand opening, today. ... in a Real Home provided by Empowered Staff. , “This is an incredibly fulfilling ...
(Date:5/26/2016)... ... May 26, 2016 , ... MadgeTech will be showcasing its line of ... New Hampshire at the MadgeTech headquarters. With products sold in more than 100 countries ... agencies, including NASA. , In 2012, NASA strategically set up 17 RHTemp101A ...
(Date:5/26/2016)... ... May 26, 2016 , ... An April Gallup survey found rising health care ... of Sun Health Senior Living (SHSL) may not share those same worries ... prescription copays for the year, while holding the line on increasing their contributions, including ...
(Date:5/26/2016)... ... 26, 2016 , ... Leadership of Life Science Logistics (LSL), ... has earned its ISO 13485 certification, indicating the company’s quality control system for ... policies associated with ISO quality standard 13485. , BSI Group America, Inc., ...
(Date:5/26/2016)... Cypress, Texas (PRWEB) , ... May 26, 2016 , ... ... on Friday, May 13 at Blackhorse Golf Club in Cypress. With the help of ... a non-profit that restores, empowers, and renews hope for wounded service members and their ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... According to a new market ... 4D), by Therapeutic Area (Oncology, Cosmeceutical/Plastic Surgery), by Application ... Manufacturers, Hospitals/ Clinics) - Forecast to 2021", published by ... for the forecast period of 2016 to 2021. This ... 2021 from USD 117.3 Million in 2016, at a ...
(Date:5/25/2016)... , Germany and ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime ... a licensing and co-development agreement with Therawis Diagnostics GmbH to ... will be to develop and market PITX2 as a marker ... other high-risk breast cancer patients. "We are pleased ...
(Date:5/25/2016)... May 25, 2016  According to Kalorama Information, the ... in 2015.  Though these are challenging times in ... for success for companies that remain optimistic and ... new growth prospects medical device companies spend a ... development (R&D) than do companies in other industries.  ...
Breaking Medicine Technology: